Global healthcare is one of the fundamental rights championed by many organizations and countries around the world. Many organizations on guenotllc.com have developed been established to provide improved medical care to people. As such, there is research done across the continent geared towards improving drugs used in treatment. Many medical practitioners have emerged to provide in-depth analysis of the health situation across medical fields. JeanMarie Guenot’s career revolves around improving the living standards of people by providing important medical care information and facilitating the development user-friendly medical drugs and appliances. Jeanmarie Guenot has over 20years of experience in the pharmaceutical and biotechnology industry.
Guenot’s expertise and professionalism started immediately she graduated with a degree from the University of California and later an MBA from the University of Pennsylvania. She has also participated in the establishment of many companies where she was involved in designing and redesigning operational efficiency. Jeanmarie Guenot is the President and Chief Executive Office of Amphivena Therapeutics which is a pharmaceutical company. She founded the SKS Ocular Company that focused on therapeutically process for ailments like muscular degeneration which has continued affecting people across the world. She has acted as an advisor to multinational companies and where she performed exceptionally well.
Amphivena Therapeutics is a medical research company that has participated in developing drugs aimed at treating chronic diseases. The center focuses mostly in developing antibody therapy that can used to treat blood cancer. Blood cancer is one of the leading cause of death among patients thus finding an appropriate drugs will save the world. The company has embarked in partnering with able minded focused individual and resource based organization in combining efforts to produce a proven and certified drugs.
Its dedicated professional medical personnel strive in producing the best type therapeutic drugs to combat and help elevate the living standards of people. The company is headquartered in Delaware, United States of America. It has expanded gradually and has an employment capacity of 10 professional employees who have been at the center of its success. The company has also raised over $14million from financing which has also impacted positively towards its development. As such, the company continues to strive in providing the best drugs globally.
Learn more about Jeanmarie Guenot: http://www.businesswire.com/news/home/20170111005414/en/Maverick-Therapeutics-Takeda-Announce-Five-year-Collaboration-Advance